Register Now for Webinar on New HIV Drugs on the Horizon
Presenter: Melanie A. Thompson, MD
Thacker & Thompson, MD
Moderator: Rajesh T. Gandhi, MD
Harvard Medical School
Friday, March 29, 2024
12:00 PM – 1:15 PM PT
Innovative medications for the treatment of people with HIV-1 continue to undergo rigorous research and development. This webinar will discuss current data around the latest pharmacologic treatments for HIV, including new data presented at the 31st Conference on Retroviruses and Opportunistic Infections, and new investigational agents in the development pipeline.
Register here: https://www.iasusa.org/events/webinar-2024-thompson/
CME Information
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. IAS-USA, the CME activity provider, will submit your participant information (eg, name, date of birth, activity credits earned, ABIM MOC number) to ABIM through the PARS system for the purpose of reporting ABIM MOC credits.
Nursing Credits
These activities are eligible for ANCC credit, see final CNE activity announcement for specific details.
Pharmacy Credits
These activities are eligible for ACPE credit, see final CPE activity announcement for specific details.